Last edition
News about "VILTEPSO "
NS Pharma Reports Preliminary Results of Viltolarsen Phase 3 Clinical Trial
NS Pharma, Inc. has received preliminary analysis results from the global Phase 3 clinical trial (RACER53 study, NCT04060199) of NS-065/NCNP-01.
VILTEPSO | 28/05/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members